Status:
UNKNOWN
Study on the Ability of Virtual Reality Glasses in Anxiety and Pain Reduction in 50 Women Undergoing Amniocentesis or Feticide
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Anxiety Acute
Amniocentesis
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Both amniocenteses and especially feticide are procedures that incorporate both anxiety and pain. As anxiety and pain can be reduced when using a distraction, The investigators speculate that the use ...
Eligibility Criteria
Inclusion
- Pregnant women undergoing amniocentesis/foeticide who will sign an informed consent form
- \-
Exclusion
- Women younger than 18 years
- Twin pregnancies
- Women with vertigo
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04491149
Start Date
September 1 2020
End Date
March 1 2021
Last Update
October 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asaf ha Rofeh, MC
Zrifin, Israel, 70300